3-环己基丙酰氯 | 39098-75-4

• 物质功能分类: 化学试剂 - 有机试剂 - 酰卤
• 分子结构分类: 有机化合物 - 有机卤素化合物 - 酰卤
• 中文名称: 3-环己基丙酰氯
• 中文别名: 环己基丙酰氯
• 英文名称: 3-cyclohexylpropionyl chloride
• 英文别名: cyclohexylpropionyl chloride；3-cyclohexylpropanoyl chloride
• CAS: 39098-75-4
• 化学式: C₉H₁₅ClO
• mdl: MFCD00066249
• 分子量: 174.671
• InChiKey: JUADTOTVJUYCRQ-UHFFFAOYSA-N

物化性质

• 沸点：
  124-126 °C (35 mmHg)
• 密度：
  1.0345
• 稳定性/保质期：

  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  C,Xn
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 海关编码：
  2916209090
• 包装等级：
  II
• 危险类别：
  8
• 危险性防范说明：
  P234,P260,P264,P271,P280,P301+P330+P331,P303+P361+P353,P304+P340,P305+P351+P338,P310,P363,P390,P403+P233,P405,P406,P501
• 危险品运输编号：
  3265
• 危险性描述：
  H290,H335,H314
• 储存条件：
  存储在阴凉干燥的环境中。

SDS

Name:	3-Cyclohexylpropionyl Chloride 96% Material Safety Data Sheet
Synonym:	None Known
CAS:	39098-75-4

Section 1 - Chemical Product MSDS Name:3-Cyclohexylpropionyl Chloride 96% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
39098-75-4	3-Cyclohexylpropionyl Chloride	96%	254-289-5

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes gastrointestinal tract burns. May cause perforation of the digestive tract. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. Aspiration may lead to pulmonary edema. May cause systemic effects.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Use only in a chemical fume hood. Discard contaminated shoes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 39098-75-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: slightly yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 124 - 126 deg C @ 35 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0345
Molecular Formula: C9H15ClO
Molecular Weight: 174.67

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 39098-75-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Cyclohexylpropionyl Chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Pseudomonas putida:

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Corrosive liquid, n.o.s.*
Hazard Class: 8
UN Number: 1760
Packing Group: II
IMO
Shipping Name: Corrosive liquid, n.o.s.
Hazard Class: 8
UN Number: 1760
Packing Group: II
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 39098-75-4: 2
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 39098-75-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 39098-75-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质：

• 密度：1.0345
• 沸点：124-126℃（4.67 kPa）
• 折光率：1.469-1.472

反应信息

• 作为反应物：
  描述：

  3-环己基丙酰氯 在 高纯二甲基镉 、 苯 作用下， 生成 4-环己基丁烷-2-酮
  参考文献：
  名称：

  The Utilization of Alkyl 2-Cyclohexylethyl Ketones in the Pfitzinger Reaction¹

  摘要：

  DOI：

  10.1021/ja01619a039
• 作为产物：
  描述：

  乙烯基环己烷 在 氯化亚砜 、 硫酸 、 过氧化苯甲酰 作用下， 生成 3-环己基丙酰氯
  参考文献：
  名称：

  Francois,H. et al., Bulletin de la Societe Chimique de France, 1970, # 2, p. 617 - 624

  摘要：

  DOI：
• 作为试剂：
  描述：

  histamine dichloride 、 草酸 、 丙酮 在 甲醇 、 sodium hydroxide 、 3-环己基丙酰氯 作用下， 以 水 、 乙酸乙酯 为溶剂， 反应 0.67h， 以21%的产率得到5-(3-cyclohexylpropanoyl)-4,4-dimethyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine oxalic acid salt
  参考文献：
  名称：

  Substituted imidazoles, their preparation and use

  摘要：

  揭示了一类新型的取代咪唑化合物，包括含有它们的药物组合物以及这些化合物在治疗和/或预防与组胺H3受体相关的疾病和紊乱中的用途。更具体地说，这些化合物对于治疗和/或预防与组胺H3受体相互作用有益的疾病和紊乱是有用的。这些咪唑化合物具有以下式I的结构，其中R1、R2、R3、R4、R5、R6、A、X、Y和Z的定义如规范中所述。

  公开号：

  US06908926B1

文献信息

• [EN] 4-HYDROXYPIPERIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19)<br/>[FR] DÉRIVÉS DE 4-HYDROXYPIPÉRIDINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PROTÉASE 19 SPÉCIFIQUE DE L'UBIQUITINE
  申请人：ALMAC DISCOVERY LTD

  公开号：WO2019150119A1

  公开（公告）日：2019-08-08

  Inhibitors of ubiquitin specific protease 19 (USP19) of Formula (I) are provided, together with pharmaceutical compositions comprising said inhibitors, and methods of use thereof. The compounds can be used in in the treatment of muscular atrophy, obesity, insulin resistance or type II diabetes or in reducing the loss of muscle mass.

  提供了公式（I）的泛素特异性蛋白酶19（USP19）的抑制剂，以及包含该抑制剂的药物组合物，以及其使用方法。这些化合物可用于治疗肌肉萎缩、肥胖、胰岛素抵抗或2型糖尿病，或减少肌肉质量的流失。
• Synthesis and biological evaluation of homoserine lactone derived ureas as antagonists of bacterial quorum sensing
  作者：Marine Frezza、Sandra Castang、Jane Estephane、Laurent Soulère、Christian Deshayes、Bernard Chantegrel、William Nasser、Yves Queneau、Sylvie Reverchon、Alain Doutheau

  DOI：10.1016/j.bmc.2006.03.017

  日期：2006.7.15

  A series of 15 racemic alkyl- and aryl-N-substituted ureas, derived from homoserine lactone, were synthesized and tested for their ability to competitively inhibit the action of 3-oxohexanoyl-l-homoserine lactone, the natural inducer of bioluminescence in the bacterium Vibrio fischeri. N-alkyl ureas with an alkyl chain of at least 4 carbon atoms, as well as certain ureas bearing a phenyl group at the

  合成了由高丝氨酸内酯衍生的一系列15种外消旋的烷基-和芳基-N-取代的脲，并测试了它们竞争抑制细菌中生物发光的天然诱导剂3-氧代己酰基-1-高丝氨酸内酯的能力。费氏弧菌。发现具有至少4个碳原子的烷基链的N-烷基脲以及某些在烷基链的末端带有苯基的脲是重要的拮抗剂。在N-丁基脲的情况下，已经表明拮抗剂活性与受体RuxR家族蛋白ExpR的N-末端结构域的二聚化的抑制有关。分子建模表明，这是由于在蛋白质酰基高丝氨酸内酯结合腔中形成了一个额外的氢键所致。
• [EN] CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA]<br/>[FR] THIAZOLES SUBSTITUÉS PAR CARBOXAMIDE OU SULFONAMIDE ET DÉRIVÉS APPARENTÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR NUCLÉAIRE ORPHELIN ROR[GAMMA]
  申请人：PHENEX PHARMACEUTICALS AG

  公开号：WO2013178362A1

  公开（公告）日：2013-12-05

  The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide or sulfonamide containing cyclic compounds of Formula (1), (1'), (100), (100'), (200) and (200') and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.

  这项发明提供了用于孤儿核受体RORγ的调节剂，以及通过向需要的人类或哺乳动物投与这些新型RORγ调节剂来治疗RORγ介导的疾病的方法。具体而言，本发明提供了含有环状化合物的羧酰胺或磺酰胺的化合物的公式（1）、（1'）、（100）、（100'）、（200）和（200'）及其对映体、二对映体、互变异构体、/V-氧化物、溶剂合物和药用可接受盐。
• [EN] SUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVES<br/>[FR] DÉRIVÉS DE MORPHOLINE ET DE THIOMORPHOLINE SUBSTITUÉS
  申请人：LUNDBECK & CO AS H

  公开号：WO2005087754A1

  公开（公告）日：2005-09-22

  The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.

  本发明涉及一般式I的吗啉和硫代吗啉衍生物或其药用盐及其用途。
• [EN] SUBSTITUTED ANILINE DERIVATIVES<br/>[FR] DERIVES D'ANILINE SUBSTITUES
  申请人：LUNDBECK & CO AS H

  公开号：WO2006029623A1

  公开（公告）日：2006-03-23

  The present invention relates to aniline derivatives of the general formula (I) or salts thereof and their use, related to their KCNQ potassium ion channel opening activity.

  本发明涉及一般式(I)的苯胺衍生物或其盐及其用途，与其KCNQ钾离子通道开放活性有关。